TipRanks
Go Ultimate55% OFF

Mark Kaye Insider Profile

18 Followers

Mark Kaye, EVP & CFO at Elevance Health, holds 19.92K shares in Elevance Health (Ticker: ELV), holds 820.00 shares in Conmed (Ticker: CNMD), holds 4.45K shares in Moody's (Ticker: MCO). Most recently, Mark Kaye Sold ― shares of Elevance Health on Oct 23, 2026 for an estimated value of $4.66M.

Mark Kaye's Trading History

ELV
Elevance Health
Oct 23, 2026EVP & CFOInformative Sell4.66M$8.37M
CNMD
Conmed
Jun 03, 2026DirectorUninformative Buy22.61K$36.32K
MCO
Moody's
Aug 08, 2023EVP & CFOUninformative Buy3.04M$2.20M

You May Also Like

Mark Kaye insider profile FAQ

What is the percentage of profitable transactions made by Mark Kaye?
The percentage of profitable transactions made by Mark Kaye is 75%.
What is the average return per transaction made by Mark Kaye?
The average return per transaction made by Mark Kaye is 2.00%.
What stocks does Mark Kaye hold?
Mark Kaye holds: ELV, CNMD, MCO stocks.
What was Mark Kaye’s latest transaction?
Mark Kaye’s latest transaction was an Informative Sell of $4.66M.
What was Mark Kaye's most profitable transaction?
Mark Kaye’s most profitable transaction was an Informative Sell of MCO stock on July 2, 2021. The return on the trade was 24.60%.
What is Mark Kaye's role in Elevance Health?
Mark Kaye's role in Elevance Health is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.